Patriot Investment Management Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Sell
7,937
-810
-9% -$139K 0.09% 95
2026
Q1
$1.48M Sell
8,747
-329
-4% -$56.3K 0.09% 91
2025
Q4
$1.53M Hold
9,076
0.1% 89
2025
Q3
$1.31M Hold
9,076
0.09% 96
2025
Q2
$1.15M Sell
9,076
-836
-8% -$103K 0.08% 103
2025
Q1
$1.27M Sell
9,912
-195
-2% -$26.4K 0.1% 91
2024
Q4
$1.34M Sell
10,107
-55
-0.5% -$7.73K 0.1% 87
2024
Q3
$1.48M Sell
10,162
-185
-2% -$26.8K 0.11% 83
2024
Q2
$1.42M Hold
10,347
0.11% 82
2024
Q1
$1.42M Sell
10,347
-2,246
-18% -$307K 0.11% 83
2023
Q4
$1.71M Sell
12,593
-172
-1% -$21K 0.15% 71
2023
Q3
$1.56M Hold
12,765
0.14% 75
2023
Q2
$1.62M Sell
12,765
-951
-7% -$124K 0.14% 78
2023
Q1
$1.77M Hold
13,716
0.16% 74
2022
Q4
$1.88M Sell
13,716
-9
-0.1% -$1.16K 0.16% 74
2022
Q3
$1.6M Sell
13,725
-22
-0.2% -$2.73K 0.17% 75
2022
Q2
$1.62M Buy
13,747
+1,322
+11% +$157K 0.16% 81
2022
Q1
$1.62M Buy
12,425
+2
+0% +$261 0.14% 83
2021
Q4
$1.9M Buy
12,423
+167
+1% +$25.9K 0.16% 73
2021
Q3
$1.98M Buy
12,256
+1,570
+15% +$264K 0.18% 68
2021
Q2
$1.75M Buy
10,686
+67
+0.6% +$10.3K 0.16% 74
2021
Q1
$1.6M Sell
10,619
-28
-0.3% -$4.45K 0.16% 77
2020
Q4
$1.61M Buy
10,647
+49
+0.5% +$7K 0.24% 52
2020
Q3
$1.44M Buy
10,598
+210
+2% +$28.5K 0.17% 70
2020
Q2
$1.42M Buy
10,388
+679
+7% +$86.6K 0.18% 72
2020
Q1
$1.05M Buy
9,709
+1,145
+13% +$132K 0.16% 79
2019
Q4
$1.03M Buy
8,564
+2
+0% +$223 0.13% 102
2019
Q3
$848K Buy
8,562
+1
+0% +$105 0.12% 111
2019
Q2
$934K Buy
8,561
+372
+5% +$39.6K 0.13% 104
2019
Q1
$915K Buy
+8,189
New +$898K 0.13% 101

Other funds holding IBB

Patriot Investment Management Group's IBB Position: Q2 2026 in Review

Patriot Investment Management Group reduced its iShares Biotechnology ETF (IBB) stake by 9.3% in Q2 2026, selling an estimated $139K and leaving 7,937 shares worth $1.51M. The position accounts for 0.09% of the portfolio, ranked #95.

Patriot Investment Management Group first reported a position in IBB in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.98M in Q3 2021. 311 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Patriot Investment Management Group held 7,937 shares of iShares Biotechnology ETF worth $1.51M as of Q2 2026.
  • Patriot Investment Management Group sold 810 iShares Biotechnology ETF shares in Q2 2026, an estimated $139K.
  • iShares Biotechnology ETF made up 0.09% of Patriot Investment Management Group's portfolio in Q2 2026, its #95 holding.
  • Patriot Investment Management Group first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 30 quarters since.
  • Patriot Investment Management Group's iShares Biotechnology ETF position peaked at $1.98M in Q3 2021.
  • 311 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Patriot Investment Management Group's 13F filing for Q2 2026, filed 15 Jul 2026.